FONTANA, Calif.--(BUSINESS WIRE)--April 11, 2006--GEN ID Lab Services Inc. (“GEN ID”) (OTC:GDLB - News) announced that in association with its news this morning on the testing for the H5N1 virus (or Bird Flu), S2 Biosciences, contracted by GEN ID, will also be cloning the entire H5N1 influenza virus genome (all three RNA segments). The clones and/or selected regions thereof will be used to develop new human vaccine candidates.
